|
| |
Image Results
Loading...
Loading...
ELAPRASE Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
Shire plc Annual Review 2008 - ELAPRASE
ELAPRASE is the first and only enzyme replacement therapy for Hunter syndrome-a rare, progressive and life-threatening condition that primarily affects boys ...
http://www.shire.com/shire/financialReports/ar2008/content/p...
|
International Approvals: Nexavar, Elaprase, Aranesp
5 Nov 2007 ... Europe has approved a new indication for sorafenib tosylate tablets (Nexavar) and an expanded indication for darbepoetin alfa (Aranesp); ...
http://www.medscape.com/viewarticle/565318...
|
Home treatment with Elaprase and Naglazyme is safe in patients ...
In this report we demonstrate the safety of home treatment with Elaprase for mucopolysaccharidosis type II (17 patients) and Naglazyme for ...
http://www.ncbi.nlm.nih.gov/pubmed/18923918...
|
International Approvals: Tysabri, Elaprase, Invega
9 Jul 2007 ... The United Kingdom has approved natalizumab intravenous infusion (Tysabri), Health Canada has approved idursulfase intravenous infusion ...
http://www.medscape.com/viewarticle/559429...
|
Japan Elaprase((R)) Treatment (JET) study: Idursulfase enzyme ...
Japan Elaprase((R)) Treatment (JET) study: Idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis ...
http://www.ncbi.nlm.nih.gov/pubmed/19773189...
|
International Approvals: Mirena, Champix, Elaprase
2 Feb 2007 ... Japan has approved a long-acting intrauterine contraceptive system (Mirena), Canada has approved varenicline tartrate tablets (Champix), ...
http://www.medscape.com/viewarticle/551678...
|
Shire Pharmaceuticals Announces Approval of ELAPRASE(R ...
27 May 2008 ... Shire Pharmaceuticals (SHPGY) Announces Approval of ELAPRASE(R) (idursulfase) in Brazil First and Only Treatment for Hunter Syndrome Now ...
http://www.biospace.com/news_story.aspx?NewsEntityId=97814...
|
International Approvals: Prexige, Elaprase, Micera
13 Aug 2007 ... Canada has approved an expanded indication for lumiracoxib tablets (Prexige) and idursulfase 2-mg/mL solution (Elaprase); ...
http://www.medscape.com/viewarticle/561315...
|
Shire Pharmaceuticals Group plc's ELAPRASE(TM) (Idursulfase ...
ELAPRASE is the first and only treatment approved for people suffering from Hunter syndrome. The product, which is given as weekly infusions, replaces the ...
http://www.biospace.com/news_story.aspx?NewsEntityId=25128...
|
DailyMed: About DailyMed
Each vial of ELAPRASE contains a 2.0 mg/mL solution of idursulfase protein (6.0 mg) .... ELAPRASE is a formulation of idursulfase, a purified form of human ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=11721...
|
|